About this Medicine article
Higher proportion of responders with hepatitis B antibody levels ≥ 100 miu/ml with the trivalent HepB vaccine, Sci-B-Vac, compared to Engerix-B: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety (PROTECT) by Vesikari, Timo; Langley, Joanne; Segall, Nathan; Ward, Brian; Cooper, Curtis; Poliquin, Guillaume; Gantt, Soren; Smith, Bruce; Van Damme, Pierre; Leroux-Roels, Isabel; Leroux-Roels, Geert; Machluf, Nathalie; Spaans, Johanna; Yassin-Rajkumar, Bebi; Anderson, David; Popovic, Vlad; Diaz-Mitoma, Francisco is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Vesikari, Timo; Langley, Joanne; Segall, Nathan; Ward, Brian; Cooper, Curtis; Poliquin, Guillaume; Gantt, Soren; Smith, Bruce; Van Damme, Pierre; Leroux-Roels, Isabel; Leroux-Roels, Geert; Machluf, Nathalie; Spaans, Johanna; Yassin-Rajkumar, Bebi; Anderson, David; Popovic, Vlad; Diaz-Mitoma, Francisco
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
- Published
- 2020
- Field
- Medicine (Health Sciences)